Table 3.
Scenario | A/E Ratio | Expected Outcome of Control Arm | Size Effect Studied | Absolute Benefit in Survival to Demonstrate the Same Benefit | Expected Outcome of Experimental Arm | Sample Size Required |
---|---|---|---|---|---|---|
Initial trial design | Not applicable | 24 mo | 1.25 | 6 mo | 30 mo | 455 patients per arm |
No. of patients to demonstrate same maintenance of absolute benefit | 1.5 | 36 mo | 1.166 | 6 mo | 40 mo | 1685 patients per arm |
No. of patients to demonstrate maintenance of effect size | 1.5 | 36 mo | 1.25 | 9 mo | 45 mo | 495 patients per arm |
Abbreviation: A/E ratio, actual‐over‐expected ratio.
Calculations were made assuming an accrual rate of 20 patients per month and a follow‐up time of 24 months for the first scenario and 36 months for the latter 2 scenarios.